THERAPEUTIC MODULATION OF THE SERINE/THREONINE PHOSPHATASE PP2A TO PREVENT RESISTANCE TO MAPK INHIBITOR THERAPY IN NSCLC

$1,390,569FY2024Defense Health AgencyDOD

Regents Of The University Of Michigan

Investigators